Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2010

01-10-2010 | American Society of Breast Surgeons

Nipple-Areolar Complex-Sparing Mastectomy: Feasibility, Patient Selection, and Technique

Authors: Gildy Babiera, MD, Rache Simmons, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2010

Login to get access

Abstract

Background

We assessed the feasibility, patient selection, and technique of nipple-areolar c omplex (NAC)-sparing mastectomy. This dynamic article includes a video that demonstrates that sentinel node biopsy or axillary dissection can be performed through the mastectomy incisions or through a separate axillary incision.

Methods

The University of Texas M. D. Anderson Cancer Center initiated a prospective study investigating the feasibility of performing NAC-sparing mastectomy in the setting of prophylaxis and breast cancer treatment. Patients selected were at low risk for skin/NAC necrosis and NAC involvement with tumor.

Results

Preliminary results of 54 breasts that underwent NAC-sparing mastectomy showed a NAC necrosis rate of 7.2%. One patient who underwent NAC-sparing prophylactic mastectomy was found to have ductal carcinoma-in-situ that was not present at the nipple base. At a median follow-up of 15 months, there has been no NAC recurrence, which is similar to other reported series of 0% to 2%. Results were comparable with other small prospective series.

Conclusions

NAC-sparing mastectomy can be performed effectively while maintaining NAC viability. The risk of leaving residual breast tissue or occult tumor with the NAC is probably low if margin assessment is performed at the base or central core of the NAC. Long-term follow-up is forthcoming on these procedures. To achieve optimal cosmetic results with oncologic safety, NAC-sparing mastectomy should only be performed in carefully selected patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brinton LA, Persson I, Boice JD Jr, et al. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer. 2001;91:478–83.CrossRefPubMed Brinton LA, Persson I, Boice JD Jr, et al. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer. 2001;91:478–83.CrossRefPubMed
2.
go back to reference Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44.CrossRefPubMed Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12:1037–44.CrossRefPubMed
3.
go back to reference Gerber B, Krause A, Dietrich M, et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249:461–8.CrossRefPubMed Gerber B, Krause A, Dietrich M, et al. The oncological safety of skin sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction: an extended follow-up study. Ann Surg. 2009;249:461–8.CrossRefPubMed
4.
go back to reference Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10.CrossRefPubMed Crowe JP, Patrick RJ, Yetman RJ, Djohan R. Nipple-sparing mastectomy update: one hundred forty-nine procedures and clinical outcomes. Arch Surg. 2008;143:1106–10.CrossRefPubMed
5.
go back to reference Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.CrossRefPubMed Sacchini V, Pinotti JA, Barros AC, et al. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem? J Am Coll Surg. 2006;203:704–14.CrossRefPubMed
6.
go back to reference Jabor MA, Shayani P, Collins DR Jr, et al. Nipple-areola reconstruction: satisfaction and clinical determinants. Plast Reconstr Surg. 2002;110:457–63.CrossRefPubMed Jabor MA, Shayani P, Collins DR Jr, et al. Nipple-areola reconstruction: satisfaction and clinical determinants. Plast Reconstr Surg. 2002;110:457–63.CrossRefPubMed
7.
go back to reference Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118:623–33.CrossRefPubMed Didier F, Radice D, Gandini S, et al. Does nipple preservation in mastectomy improve satisfaction with cosmetic results, psychological adjustment, body image and sexuality? Breast Cancer Res Treat. 2009;118:623–33.CrossRefPubMed
8.
go back to reference Stolier AJ, Grube BJ. Areola-sparing mastectomy: defining the risks. J Am Coll Surg. 2005;201:118–24.CrossRefPubMed Stolier AJ, Grube BJ. Areola-sparing mastectomy: defining the risks. J Am Coll Surg. 2005;201:118–24.CrossRefPubMed
9.
go back to reference Brachtel EF, Rusby JE, Michaelson JS, et al. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. J Clin Oncol. 2009;27:4949–55.CrossRef Brachtel EF, Rusby JE, Michaelson JS, et al. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens. J Clin Oncol. 2009;27:4949–55.CrossRef
Metadata
Title
Nipple-Areolar Complex-Sparing Mastectomy: Feasibility, Patient Selection, and Technique
Authors
Gildy Babiera, MD
Rache Simmons, MD
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1256-0

Other articles of this Special Issue 3/2010

Annals of Surgical Oncology 3/2010 Go to the issue

American Society of Breast Surgeons

Pure Tubular Carcinoma and Axillary Nodal Metastases